Immutep
IMMP
6 hedge funds and large institutions have $1.02M invested in Immutep in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.
0% less ownership
Funds ownership: 0.02% → 0.02% (-0%)
25% less funds holding
Funds holding: 8 → 6 (-2)
37% less capital invested
Capital invested by funds: $1.61M → $1.02M (-$587K)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$10.1K |
| 2 |
Renaissance Technologies
New York
|
+$8.99K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$956 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$190K |
| 2 |
PC
Polar Capital
London,
United Kingdom
|
-$77.9K |
| 3 |
CWM
Cornerstone Wealth Management
St. Peters,
Missouri
|
-$43K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$25K |
| 5 |
VWM
Valley Wealth Managers
Paramus,
New Jersey
|
-$22K |
IMMP Hedge Fund Activity: Q2 2019 in Review
6 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Immutep (IMMP) for Q2 2019, worth a combined $1.02M — down 37% from $1.61M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of IMMP and 2 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, opening a new position worth an estimated $10.1K. The largest seller was Morgan Stanley, cutting an estimated $190K.
- 6 institutional investors held Immutep (IMMP) as of Q2 2019, down from 8 in Q1 2019.
- Funds reported $1.02M of Immutep stock for Q2 2019, down 37% quarter-over-quarter.
- 2 funds opened new Immutep positions in Q2 2019 and 4 closed out, a net change of -2 holders.
- The largest Immutep buyer in Q2 2019 was UBS Group, an estimated $10.1K added.
- The largest Immutep seller in Q2 2019 was Morgan Stanley, an estimated $190K sold.
Based on aggregated 13F filings for Q2 2019.